We are monitoring the impact of COVID-19 on Europe RNA Analysis Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4385
Share on
Share on

Europe RNA Analysis Market Research Report - Segmented By End User, Type, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, Growth, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4385
Pages: 136

Europe RNA Analysis Market Size (2020 to 2025)

The size of the Europe RNA Analysis Market is forecasted to worth USD 1.16 Billion by 2025 from USD 0.61 Billion in 2020, showcasing a CAGR of 13.8% from 2020 to 2025.

Increasing research and development activities in RNA sequencing and transcriptomics by biotechnology and pharmaceutical industries is predicted as one of the prime factors boosting the growth. Growing funds from government and private organizations and increasing significance for personalized medicines are to accelerate the market. For instance, Regeneron Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. have made partnership in developing RNA therapies for chronic liver diseases and non-alcoholic steatohepatitis and efficiently other relevant diseases. Rising demand for these therapies for their wide range of applications for unsatisfied medical circumstances is propelling the need for the market.

The shortage of experienced professionals in the RNA sector, deficit of systematic bioinformatics, and data analysis tools to determine massive data produced from high throughput screening technologies are factors acting as a barrier in the RNA analysis market. Moreover, a high failure rate is expected to impede the market.

This research report on the Europe RNA Analysis Market has been segmented and sub-segmented into the following categories:

  • By Type: Microarrays (Reagents, Instruments, Software), Polymerase Chain Reaction (PCR), Sequencing Technologies, RNAi Gene Silencing)
  • By Application: Clinical Diagnosis, Drug Discovery, Toxic genomics.
  • By End User: Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centres
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe

Regional Analysis:

Europe is next to North America is dominating the RNA analysis market during the period. This region is accounted for as the second-largest market in the RNA analysis market. Significant investments in research and advancements in RNA platform technologies are adding fuel to the market growth. Increasing government support for RNA based therapies and accessibility of proper infrastructure in enhancing the RNA market is to propel the market growth in the region. 

Germany is governing the market with extensive applications in the biotechnology and pharmaceutical sectors and utilized in drug discovery, clinical diagnostic applications, and life science research to accelerate the market in this region. Also, the rise in awareness for selected products and the mounting occurrence rate of chronic diseases. The above-aforementioned factors are about to drive the market of this region. 

UK is just behind the UK in having the next highest share in the RNA analysis market due to massive spending on research and development and surging market growth. Growing consideration of legislative bodies in improving reimbursement policies has escalated the expansion in the region. Moreover, the particularity and choosiness of RNAi therapies, R&D activities, and robust products and widespread usage of RNA sequencing and a growing number of pharmaceutical industries are likely to accelerate the RNA analysis market in the European region.

Prominent Companies dominating the Europe RNA Analysis Market Profiled in the Report are Illumina Inc, Qiagen N.V, Affymetrix Inc, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, Sigma Aldrich, Fluidigm Corporation, Bio-Rad Laboratories Inc, GE Healthcare, and Thermofisher Scientific Inc.

1. Introduction               

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods        

                1.4 General Study Assumptions 

2. Research Methodology                         

                2.1 Introduction             

                2.2 Research Phases    

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview                     

                3.1 Executive Summary 

                3.2 Key Inferences       

                3.3 Epidemiology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                  

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market            

5. Market Segmentation                            

                5.1 End-User    

                                5.1.1 Introduction                                                           

                                5.1.2 Academic Research & Government Institutes                                                         

                                5.1.3 Pharmaceutical & Biotechnology Companies                                                           

                                5.1.4 Hospitals & Diagnostic Centers                                                       

                                5.1.5  Y-o-Y Growth Analysis, By End User                                                            

                                5.1.6  Market Attractiveness Analysis, By End User                                                          

                                5.1.7  Market Share Analysis, By End User                                                            

                5.2 Type            

                                5.2.1 Introduction                                                           

                                5.2.2 Microarrays                                                            

                                                5.2.2.1 Reagents                                              

                                                5.2.2.2 Instruments                                        

                                                5.2.2.3 Software                                              

                                5.2.3 Polymerase Chain Reaction (PCR)                                                 

                                                5.2.3.1 Reagents                                              

                                                5.2.3.2 Instruments                                        

                                                5.2.3.3 Software                                              

                                5.2.4 Sequencing Technologies                                                 

                                                5.2.4.1 Sanger Sequencing                                          

5.2.4.1.1 Reagents                          

5.2.4.1.2 Instruments                    

5.2.4.1.3 Software                          

                                                5.2.4.2 Next Generation Sequencing (NGS)                                        

5.2.4.2.1 Reagents                          

5.2.4.2.2 Instruments                    

5.2.4.2.3 Software                          

                                5.2.5 RNAi Gene Silencing                                                           

                                                5.2.5.1 Reagents                                              

                                                5.2.5.2 Instruments                                        

                                                5.2.5.3 Software                                              

                                5.2.6 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.7 Market Attractiveness Analysis, By Type                                                   

                                5.2.8 Market Share Analysis, By Type                                                     

                5.3 Application  

                                5.3.1 Introduction                                                           

                                5.3.2 Clinical Diagnosis                                                   

                                5.3.3 Drug Discovery                                                      

                                5.3.4 Toxicogenomics                                                    

                                5.3.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.3.6  Market Attractiveness Analysis, By Application                                                      

                                5.3.7  Market Share Analysis, By Application                                                       

6. Geographical Analysis                            

                6.1 Introduction             

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By End User                                        

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By End User                                        

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By Application                                    

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By End User                                        

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By Application                                    

                6.2 U.K  

                6.3 Spain           

                6.4 Germany   

                6.5 Italy             

                6.6 France        

                6.7 Rest of Europe

7. Strategic Analysis                     

                7.1 PESTLE analysis       

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis            

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                      

                8.1 Affymetrix Inc.        

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Agilent Technologies, Inc.  

                8.3 Bio-Rad Laboratories, Inc.  

                8.4 GE Healthcare         

                8.5 Illumina, Inc.            

                8.6 Qiagen N.V.              

                8.7 F. Hoffmann-La Roche Ltd

                  8.8 Sigma-Aldrich Corporation  

                8.9 Thermo Fisher Scientific, Inc.          

                8.10 Fluidigm Corporation

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of end user, type and application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  2. Europe Microarray Market By Region, From 2020-2025 ( USD Billion )
  3. Europe PCR Market By Region, From 2020-2025 ( USD Billion )
  4. Europe Sequencing Market By Region, From 2020-2025 ( USD Billion )
  5. Europe RNAi Gene Silencing Market By Region, From 2020-2025 ( USD Billion )
  6. Europe RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  7. Europe Clinical Diagnostics Market By Region, From 2020-2025 ( USD Billion )
  8. Europe Drug Discovery Market By Region, From 2020-2025 ( USD Billion )
  9. Europe Toxicogenomics Market By Region, From 2020-2025 ( USD Billion )
  10. Europe RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )
  11. Europe Pharmaceutical and biotechnology Companies Market By Region, From 2020-2025 ( USD Billion )
  12. Europe Academic Research and Government Institutes Market By Region, From 2020-2025 ( USD Billion )
  13. Europe Hospitals and Diagnostic Centers Market By Region, From 2020-2025 ( USD Billion )
  14. U.K. RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  15. U.K. RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  16. U.K. RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )
  17. Germany RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  18. Germany RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  19. Germany RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )
  20. France RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  21. France RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  22. France RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )
  23. Italy RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  24. Italy RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  25. Italy RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )
  26. Spain RNA Analysis Market By Technology, From 2020-2025 ( USD Billion )
  27. Spain RNA Analysis Market By Applications, From 2020-2025 ( USD Billion )
  28. Spain RNA Analysis Market By End-users, From 2020-2025 ( USD Billion )s

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample